Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Cutaneous × tofacitinib × Clear all

NCT06698822 2026-04-14

A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous